Virus-specific T cell therapy marks a new era in precision medicine. By isolating and expanding T cells that target viral pathogens, clinicians can restore immune balance in vulnerable patients. This approach has shown promising clinical success against EBV, CMV, and adenovirus infections. Xellera Therapeutics is dedicated to pioneering next-generation VST platforms to transform infec... https://www.xelleratherapeutics.com/services/custom-manufacturing-services/